Clinical Trial Update: Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and preliminary efficacy of an oral rinse (BLXA4-ME) for gingival inflammation shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingival Inflammation

Drugs mentioned

• BLXA4-ME

Snippet

Sponsor: The Forsyth Institute | Conditions: Gingival Inflammation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-20